Evolus, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
EOLS on Nasdaq
Industry
Pharmaceutical Preparations
Location
520 Newport Center Drive, Suite 1200, Newport Beach, CA

Insiders trading volume in the past year

Evolus, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Alphaeon 1 LLC 10%+ Owner $35.4M Feb 17, 2023
Medytox Inc. Former 10% Owner $25.4M Oct 16, 2023
Simone Blank Director $6.08M Mar 7, 2025
David Moatazedi President & Chief Executive Officer, Director $5.68M -$3M -34.6% Jun 13, 2025
Rui Avelar Chief Medical Officer & Head of Research and Development $3.8M -$428K -10.1% May 12, 2025
Vikram Malik Director $2.76M Mar 7, 2025
Sandra Beaver Chief Financial Officer $2.06M -$202K -8.91% May 13, 2025
Lauren P. Silvernail Chief Financial Officer and Executive Vice President, Corporate Development $1.38M May 17, 2022
Crystal Muilenburg Chief Marketing Officer $1.31M Mar 8, 2022
Tomoko Yamagishi-Dressler Chief Marketing Officer $869K -$103K -10.6% Aug 22, 2025
Robert Hayman Director $857K Feb 7, 2024
Tatjana Mitchell Chief Financial Officer $642K Sep 8, 2025
Brady Stewart Director $604K +$204K +51.2% Aug 15, 2025
Peter C. Farrell Director $517K Jan 27, 2023
Albert G. White III Director $476K +$189K +65.8% Jun 9, 2025
David N. Gill Director $448K Mar 7, 2025
Karah Parschauer Director $418K -$167K -28.6% Mar 12, 2025

Recent Insider Transactions by Companies or Individuals for Evolus, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.